These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4177692)

  • 1. Presence of corpus luteum as evidence of ovulation in women treated with low doses of chlormadinone acetate.
    Gutiérrez-Nájar A; Márquez-Monter H; Giner-Velázquez J; Martínez-Manautou J
    Am J Obstet Gynecol; 1968 Dec; 102(7):1018-22. PubMed ID: 4177692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose oral products.
    IPPF Med Bull; 1967; 1(4):2. PubMed ID: 12254702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlormadinone acetate as an oral contraceptive.
    Rao AP
    J Obstet Gynaecol India; 1970 Oct; 20(5):735-41. PubMed ID: 12254495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of nor-ethisterone enanthate on the structure of ovary, particularly corpus luteum.
    Aghari K
    J Obstet Gynaecol India; 1970 Jun; 20(3):393-6. PubMed ID: 12275253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose progestagens as contraceptive agents.
    Elstein M
    IPPF Med Bull; 1970; 4(1):2-4. PubMed ID: 12255089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous low dose progestagen for contraception.
    Martinez-manautou J
    IPPF Med Bull; 1968; 2(5):2-3. PubMed ID: 12155573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different contraceptives upon the ovulation changes of the morphological study of the ovaries.
    Bedoya Havia M; Kesseur E; Garcia La Madrid M
    Ginecol Obstet (Lima); 1967 Dec; 13(3):177-92. PubMed ID: 12277382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 17alpha-ethinyl-19-nortestosterone (ENT) on corpus luteum function.
    Lehmann F; Just-Nastansky I; Czygan PJ; Bettendorf G
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(4):219-22. PubMed ID: 987942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine effects of two new retro-steroids in animal models and in women.
    Morsink L; de Wachter AM; Brenner P; Cekan SZ; Guerrero R; Hagenfeldt K; Diczfalusy E
    Acta Endocrinol (Copenh); 1976 May; 82(1):193-212. PubMed ID: 57688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
    Yassin S; El-mahgoub S; Ammar R; Karim M
    Ain Shams Med J; 1971 Jul; 22(4):497-501. PubMed ID: 12256861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian morphologyy after prolonged use of steroid contraceptive agents.
    Maqueo M; Rice-Wray E; Calderon JJ; Goldzieher JW
    Contraception; 1972 Mar; 5(3):177-85. PubMed ID: 4119577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anovular corpus luteum in a woman taking an oral contraceptive.
    Ludwig KS; Horowitz M
    Obstet Gynecol; 1969 May; 33(5):696-702. PubMed ID: 5778449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound scanning of ovaries to detect ovulation in women.
    Queenan JT; O'Brien GD; Bains LM; Simpson J; Collins WP; Campbell S
    Fertil Steril; 1980 Aug; 34(2):99-105. PubMed ID: 7409241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.